{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T08:04:05Z","timestamp":1785485045552,"version":"3.56.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T00:00:00Z","timestamp":1686528000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T00:00:00Z","timestamp":1686528000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100019217","name":"Institut de Valorisation des Donn\u00e9es","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019217","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec - Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Chaire Eli Lilly Canada de recherche en schizophr\u00e9nie"},{"DOI":"10.13039\/501100010785","name":"Canada First Research Excellence Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010785","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018864","name":"Otsuka Canada Pharmaceutical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018864","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Emotional responses are an important component of psychotherapeutic processes. Avatar therapy (AT) is a virtual reality-based therapy currently being developed and studied for patients suffering from treatment resistant schizophrenia. Considering the importance of identifying emotions in therapeutical processes and their impact on the therapeutic outcome, an exploration of such emotions is needed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The aim of this study is to identify the underlying emotions at the core of the patient-Avatar interaction during AT by content analysis of immersive sessions transcripts and audio recordings. A content analysis of AT transcripts and audio recordings using iterative categorization was conducted for 16 patients suffering from TRS who underwent AT between 2017 and 2022 (128 transcripts and 128 audio recordings). An iterative categorization technique was conducted to identify the different emotions expressed by the patient and the Avatar during the immersive sessions.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The following emotions were identified in this study: Anger, Contempt\/ Disgust, Fear, Sadness, Shame\/ Embarrassment, Interest, Surprise, Joy and Neutral. Patients expressed mostly neutral, joy and anger emotions whereas the Avatar expressed predominantly interest, disgust\/contempt, and neutral emotions.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This study portrays a first qualitative insight on the emotions that are expressed in AT and serves as a steppingstone for further investigation in the role of emotions in the therapeutic outcomes of AT.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12888-023-04861-2","type":"journal-article","created":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T09:02:23Z","timestamp":1686560543000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Exploration of the role of emotional expression of treatment-resistant schizophrenia patients having followed virtual reality therapy: a content analysis"],"prefix":"10.1186","volume":"23","author":[{"given":"Alexandre","family":"Hudon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Lammatteo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Rodrigues-Coutl\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Dellazizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Gigu\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kingsada","family":"Phraxayavong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Potvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Dumais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,12]]},"reference":[{"key":"4861_CR1","doi-asserted-by":"publisher","first-page":"15067","DOI":"10.1038\/nrdp.2015.67","volume":"1","author":"RS Kahn","year":"2015","unstructured":"Kahn RS, Sommer IE, Murray RM, Meyer-Lindenberg A, Weinberger DR, Cannon TD, et al. Schizophrenia Nat Rev Dis Primers. 2015;1:15067.","journal-title":"Schizophrenia Nat Rev Dis Primers"},{"issue":"1","key":"4861_CR2","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s40273-016-0444-6","volume":"35","author":"H Jin","year":"2017","unstructured":"Jin H, Mosweu I. The Societal cost of Schizophrenia: a systematic review. PharmacoEconomics. 2017;35(1):25\u201342.","journal-title":"PharmacoEconomics"},{"key":"4861_CR3","doi-asserted-by":"crossref","unstructured":"Kadakia A, Catillon M, Fan Q, Williams GR, Marden JR, Anderson A et al. The Economic Burden of Schizophrenia in the United States. J Clin Psychiatry. 2022;83(6).","DOI":"10.4088\/JCP.22m14458"},{"issue":"6","key":"4861_CR4","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/89040","volume":"7","author":"GK Thaker","year":"2001","unstructured":"Thaker GK, Carpenter WT. Jr. Advances in schizophrenia. Nat Med. 2001;7(6):667\u201371.","journal-title":"Nat Med"},{"issue":"2","key":"4861_CR5","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1001\/jamapsychiatry.2019.3360","volume":"77","author":"RA McCutcheon","year":"2020","unstructured":"McCutcheon RA, Reis Marques T, Howes OD. Schizophrenia-An Overview. JAMA Psychiatry. 2020;77(2):201\u201310.","journal-title":"JAMA Psychiatry"},{"issue":"10","key":"4861_CR6","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1001\/jamapsychiatry.2022.2386","volume":"79","author":"SJ Abplanalp","year":"2022","unstructured":"Abplanalp SJ, Braff DL, Light GA, Nuechterlein KH, Green MF, Consortium on the Genetics of S. Understanding connections and boundaries between positive symptoms, negative symptoms, and role functioning among individuals with Schizophrenia: A Network Psychometric Approach. JAMA Psychiatry. 2022;79(10):1014\u201322.","journal-title":"JAMA Psychiatry"},{"key":"4861_CR7","first-page":"47","volume":"5","author":"R Brisch","year":"2014","unstructured":"Brisch R, Saniotis A, Wolf R, Bielau H, Bernstein HG, Steiner J, et al. The role of dopamine in schizophrenia from a neurobiological and evolutionary perspective: old fashioned, but still in vogue. Front Psychiatry. 2014;5:47.","journal-title":"Front Psychiatry"},{"issue":"1\u20133","key":"4861_CR8","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.schres.2015.08.041","volume":"169","author":"LA McCollum","year":"2015","unstructured":"McCollum LA, Roberts RC. Uncovering the role of the nucleus accumbens in schizophrenia: a postmortem analysis of tyrosine hydroxylase and vesicular glutamate transporters. Schizophr Res. 2015;169(1\u20133):369\u201373.","journal-title":"Schizophr Res"},{"issue":"1","key":"4861_CR9","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/s41398-021-01589-z","volume":"11","author":"K Danielsson","year":"2021","unstructured":"Danielsson K, Stomberg R, Adermark L, Ericson M, Soderpalm B. Differential dopamine release by psychosis-generating and non-psychosis-generating addictive substances in the nucleus accumbens and dorsomedial striatum. Transl Psychiatry. 2021;11(1):472.","journal-title":"Transl Psychiatry"},{"issue":"3","key":"4861_CR10","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.tins.2018.12.004","volume":"42","author":"RA McCutcheon","year":"2019","unstructured":"McCutcheon RA, Abi-Dargham A, Howes OD, Schizophrenia. Dopamine and the striatum: from Biology to symptoms. Trends Neurosci. 2019;42(3):205\u201320.","journal-title":"Trends Neurosci"},{"key":"4861_CR11","doi-asserted-by":"publisher","first-page":"519","DOI":"10.2147\/NDT.S225643","volume":"16","author":"CU Correll","year":"2020","unstructured":"Correll CU, Schooler NR. Negative symptoms in Schizophrenia: a review and clinical guide for Recognition, Assessment, and treatment. Neuropsychiatr Dis Treat. 2020;16:519\u201334.","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"2","key":"4861_CR12","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.yebeh.2011.11.004","volume":"23","author":"T Butler","year":"2012","unstructured":"Butler T, Weisholtz D, Isenberg N, Harding E, Epstein J, Stern E, et al. Neuroimaging of frontal-limbic dysfunction in schizophrenia and epilepsy-related psychosis: toward a convergent neurobiology. Epilepsy Behav. 2012;23(2):113\u201322.","journal-title":"Epilepsy Behav"},{"issue":"3","key":"4861_CR13","doi-asserted-by":"publisher","first-page":"180","DOI":"10.4103\/0019-5545.55084","volume":"51","author":"JP John","year":"2009","unstructured":"John JP. Fronto-temporal dysfunction in schizophrenia: a selective review. Indian J Psychiatry. 2009;51(3):180\u201390.","journal-title":"Indian J Psychiatry"},{"issue":"2","key":"4861_CR14","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s00213-018-5133-z","volume":"236","author":"RC Smith","year":"2019","unstructured":"Smith RC, Leucht S, Davis JM. Maximizing response to first-line antipsychotics in schizophrenia: a review focused on finding from meta-analysis. Psychopharmacology. 2019;236(2):545\u201359.","journal-title":"Psychopharmacology"},{"issue":"9","key":"4861_CR15","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/S2215-0366(17)30270-5","volume":"4","author":"Y Zhu","year":"2017","unstructured":"Zhu Y, Krause M, Huhn M, Rothe P, Schneider-Thoma J, Chaimani A, et al. Antipsychotic drugs for the acute treatment of patients with a first episode of schizophrenia: a systematic review with pairwise and network meta-analyses. Lancet Psychiatry. 2017;4(9):694\u2013705.","journal-title":"Lancet Psychiatry"},{"issue":"1","key":"4861_CR16","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1093\/bmb\/ldv017","volume":"114","author":"J Lally","year":"2015","unstructured":"Lally J, MacCabe JH. Antipsychotic medication in schizophrenia: a review. Br Med Bull. 2015;114(1):169\u201379.","journal-title":"Br Med Bull"},{"key":"4861_CR17","doi-asserted-by":"publisher","first-page":"994425","DOI":"10.3389\/fpsyt.2022.994425","volume":"13","author":"A Pandey","year":"2022","unstructured":"Pandey A, Kalita KN. Treatment-resistant schizophrenia: how far have we traveled? Front Psychiatry. 2022;13:994425.","journal-title":"Front Psychiatry"},{"key":"4861_CR18","doi-asserted-by":"publisher","first-page":"104257","DOI":"10.1016\/j.nbd.2018.08.016","volume":"131","author":"FC Nucifora Jr","year":"2019","unstructured":"Nucifora FC Jr, Woznica E, Lee BJ, Cascella N, Sawa A. Treatment resistant schizophrenia: clinical, biological, and therapeutic perspectives. Neurobiol Dis. 2019;131:104257.","journal-title":"Neurobiol Dis"},{"issue":"1","key":"4861_CR19","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1192\/j.eurpsy.2020.72","volume":"63","author":"M Bioque","year":"2020","unstructured":"Bioque M, Parellada E, Garcia-Rizo C, Amoretti S, Fortea A, Oriolo G, et al. Clozapine and paliperidone palmitate antipsychotic combination in treatment-resistant schizophrenia and other psychotic disorders: a retrospective 6-month mirror-image study. Eur Psychiatry. 2020;63(1):e71.","journal-title":"Eur Psychiatry"},{"issue":"7","key":"4861_CR20","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1001\/jamapsychiatry.2017.0624","volume":"74","author":"CU Correll","year":"2017","unstructured":"Correll CU, Rubio JM, Inczedy-Farkas G, Birnbaum ML, Kane JM, Leucht S. Efficacy of 42 pharmacologic cotreatment strategies added to antipsychotic monotherapy in Schizophrenia: systematic overview and Quality Appraisal of the Meta-analytic evidence. JAMA Psychiatry. 2017;74(7):675\u201384.","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"4861_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41537-019-0090-z","volume":"6","author":"SG Potkin","year":"2020","unstructured":"Potkin SG, Kane JM, Correll CU, Lindenmayer JP, Agid O, Marder SR, et al. The neurobiology of treatment-resistant schizophrenia: paths to antipsychotic resistance and a roadmap for future research. NPJ Schizophr. 2020;6(1):1.","journal-title":"NPJ Schizophr"},{"issue":"3","key":"4861_CR22","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1002\/wps.20577","volume":"17","author":"I Bighelli","year":"2018","unstructured":"Bighelli I, Salanti G, Huhn M, Schneider-Thoma J, Krause M, Reitmeir C, et al. Psychological interventions to reduce positive symptoms in schizophrenia: systematic review and network meta-analysis. World Psychiatry. 2018;17(3):316\u201329.","journal-title":"World Psychiatry"},{"issue":"1","key":"4861_CR23","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1186\/s12888-018-1964-8","volume":"18","author":"I Bighelli","year":"2018","unstructured":"Bighelli I, Huhn M, Schneider-Thoma J, Krause M, Reitmeir C, Wallis S, et al. Response rates in patients with schizophrenia and positive symptoms receiving cognitive behavioural therapy: a systematic review and single-group meta-analysis. BMC Psychiatry. 2018;18(1):380.","journal-title":"BMC Psychiatry"},{"issue":"1","key":"4861_CR24","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1192\/bjp.bp.112.116285","volume":"204","author":"S Jauhar","year":"2014","unstructured":"Jauhar S, McKenna PJ, Radua J, Fung E, Salvador R, Laws KR. Cognitive-behavioural therapy for the symptoms of schizophrenia: systematic review and meta-analysis with examination of potential bias. Br J Psychiatry. 2014;204(1):20\u20139.","journal-title":"Br J Psychiatry"},{"issue":"2","key":"4861_CR25","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1080\/17522439.2013.773457","volume":"6","author":"J Leff","year":"2014","unstructured":"Leff J, Williams G, Huckvale M, Arbuthnot M, Leff AP. Avatar therapy for persecutory auditory hallucinations: what is it and how does it work? Psychosis. 2014;6(2):166\u201376.","journal-title":"Psychosis"},{"issue":"1","key":"4861_CR26","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S2215-0366(17)30427-3","volume":"5","author":"TK Craig","year":"2018","unstructured":"Craig TK, Rus-Calafell M, Ward T, Leff JP, Huckvale M, Howarth E, et al. AVATAR therapy for auditory verbal hallucinations in people with psychosis: a single-blind, randomised controlled trial. Lancet Psychiatry. 2018;5(1):31\u201340.","journal-title":"Lancet Psychiatry"},{"issue":"5","key":"4861_CR27","first-page":"CD011898","volume":"5","author":"G Aali","year":"2020","unstructured":"Aali G, Kariotis T, Shokraneh F. Avatar Therapy for people with schizophrenia or related disorders. Cochrane Database Syst Rev. 2020;5(5):CD011898.","journal-title":"Cochrane Database Syst Rev"},{"key":"4861_CR28","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.schres.2018.02.031","volume":"197","author":"OP du Sert","year":"2018","unstructured":"du Sert OP, Potvin S, Lipp O, Dellazizzo L, Laurelli M, Breton R, et al. Virtual reality therapy for refractory auditory verbal hallucinations in schizophrenia: a pilot clinical trial. Schizophr Res. 2018;197:176\u201381.","journal-title":"Schizophr Res"},{"issue":"3","key":"4861_CR29","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1002\/cpp.2556","volume":"28","author":"M Beaudoin","year":"2021","unstructured":"Beaudoin M, Potvin S, Machalani A, Dellazizzo L, Bourguignon L, Phraxayavong K, et al. The therapeutic processes of avatar therapy: a content analysis of the dialogue between treatment-resistant patients with schizophrenia and their avatar. Clin Psychol Psychother. 2021;28(3):500\u201318.","journal-title":"Clin Psychol Psychother"},{"issue":"4","key":"4861_CR30","doi-asserted-by":"crossref","first-page":"146045822211424","DOI":"10.1177\/14604582221142442","volume":"28","author":"A Hudon","year":"2022","unstructured":"Hudon A, Beaudoin M, Phraxayavong K, Dellazizzo L, Potvin S, Dumais A. Implementation of a machine learning algorithm for automated thematic annotations in avatar: a linear support vector classifier approach. Health Inf J. 2022;28(4):14604582221142442.","journal-title":"Health Inf J"},{"issue":"3","key":"4861_CR31","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1002\/cpp.2680","volume":"29","author":"M Abargil","year":"2022","unstructured":"Abargil M, Tishby O. How therapists\u2019 emotion recognition relates to therapy process and outcome. Clin Psychol Psychother. 2022;29(3):1001\u201319.","journal-title":"Clin Psychol Psychother"},{"issue":"5","key":"4861_CR32","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1159\/000501621","volume":"88","author":"M Kleinstauber","year":"2019","unstructured":"Kleinstauber M, Allwang C, Bailer J, Berking M, Brunahl C, Erkic M, et al. Cognitive Behaviour Therapy complemented with emotion regulation training for patients with persistent physical symptoms: a Randomised Clinical Trial. Psychother Psychosom. 2019;88(5):287\u201399.","journal-title":"Psychother Psychosom"},{"key":"4861_CR33","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.janxdis.2018.03.003","volume":"55","author":"RM Butler","year":"2018","unstructured":"Butler RM, Boden MT, Olino TM, Morrison AS, Goldin PR, Gross JJ, et al. Emotional clarity and attention to emotions in cognitive behavioral group therapy and mindfulness-based stress reduction for social anxiety disorder. J Anxiety Disord. 2018;55:31\u20138.","journal-title":"J Anxiety Disord"},{"key":"4861_CR34","doi-asserted-by":"publisher","first-page":"104249","DOI":"10.1016\/j.cognition.2020.104249","volume":"200","author":"CM Whiting","year":"2020","unstructured":"Whiting CM, Kotz SA, Gross J, Giordano BL, Belin P. The perception of caricatured emotion in voice. Cognition. 2020;200:104249.","journal-title":"Cognition"},{"issue":"3","key":"4861_CR35","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1080\/02699931.2021.2021144","volume":"36","author":"M Kikutani","year":"2022","unstructured":"Kikutani M, Ikemoto M. Detecting emotion in speech expressing incongruent emotional cues through voice and content: investigation on dominant modality and language. Cogn Emot. 2022;36(3):492\u2013511.","journal-title":"Cogn Emot"},{"issue":"1","key":"4861_CR36","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41537-021-00139-2","volume":"7","author":"L Dellazizzo","year":"2021","unstructured":"Dellazizzo L, Potvin S, Phraxayavong K, Dumais A. One-year randomized trial comparing virtual reality-assisted therapy to cognitive-behavioral therapy for patients with treatment-resistant schizophrenia. NPJ Schizophr. 2021;7(1):9.","journal-title":"NPJ Schizophr"},{"issue":"2","key":"4861_CR37","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1080\/10503309212331332904","volume":"2","author":"E Mergenthaler","year":"2010","unstructured":"Mergenthaler E, Stinson C. Psychotherapy transcription Standards. Psychother Res. 2010;2(2):125\u201342.","journal-title":"Psychother Res"},{"issue":"6","key":"4861_CR38","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1111\/add.13314","volume":"111","author":"J Neale","year":"2016","unstructured":"Neale J. Iterative categorization (IC): a systematic technique for analysing qualitative data. Addiction. 2016;111(6):1096\u2013106.","journal-title":"Addiction"},{"issue":"4","key":"4861_CR39","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1037\/0003-066X.48.4.384","volume":"48","author":"P Ekman","year":"1993","unstructured":"Ekman P. Facial expression and emotion. Am Psychol. 1993;48(4):384\u201392.","journal-title":"Am Psychol"},{"key":"4861_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev.psych.60.110707.163539","volume":"60","author":"CE Izard","year":"2009","unstructured":"Izard CE. Emotion theory and research: highlights, unanswered questions, and emerging issues. Annu Rev Psychol. 2009;60:1\u201325.","journal-title":"Annu Rev Psychol"},{"key":"4861_CR41","first-page":"267","volume-title":"The specific Affect Coding System (SPAFF). Handbook of emotion elicitation and assessment. Series in affective science","author":"JA Coan","year":"2007","unstructured":"Coan JA, Gottman JM. The specific Affect Coding System (SPAFF). Handbook of emotion elicitation and assessment. Series in affective science. New York, NY, US: Oxford University Press; 2007. pp. 267\u201385."},{"key":"4861_CR42","doi-asserted-by":"crossref","unstructured":"Sbattella L, Colombo L, Rinaldi C, Tedesco R, Matteucci M, Trivilini A, editors. Extracting Emotions and Communication Styles from vocal signals. PhyCS; 2014.","DOI":"10.1007\/978-3-662-45686-6_2"},{"issue":"4","key":"4861_CR43","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1080\/10503307.2013.784421","volume":"23","author":"D Rochman","year":"2013","unstructured":"Rochman D, Amir O. Examining in-session expressions of emotions with speech\/vocal acoustic measures: an introductory guide. Psychother Res. 2013;23(4):381\u201393.","journal-title":"Psychother Res"},{"key":"4861_CR44","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.chb.2018.05.035","volume":"87","author":"M Lyons","year":"2018","unstructured":"Lyons M, Aksayli ND, Brewer G. Mental distress and language use: linguistic analysis of discussion forum posts. Comput Hum Behav. 2018;87:207\u201311.","journal-title":"Comput Hum Behav"},{"issue":"2","key":"4861_CR45","doi-asserted-by":"publisher","first-page":"126","DOI":"10.18778\/1733-8077.4.2.06","volume":"4","author":"P Chomczynski","year":"2008","unstructured":"Chomczynski P. QDA MINER \u2013 the mixed method solution for qualitative analysis by Provalis Research. Qualitative Sociol Rev. 2008;4(2):126\u20139.","journal-title":"Qualitative Sociol Rev"},{"key":"4861_CR46","doi-asserted-by":"crossref","unstructured":"Given LM. The sage encyclopedia of qualitative research methods. Sage publications; 2008.","DOI":"10.4135\/9781412963909"},{"issue":"1","key":"4861_CR47","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1186\/s12888-022-04010-1","volume":"22","author":"M Rus-Calafell","year":"2022","unstructured":"Rus-Calafell M, Ehrbar N, Ward T, Edwards C, Huckvale M, Walke J, et al. Participants\u2019 experiences of AVATAR therapy for distressing voices: a thematic qualitative evaluation. BMC Psychiatry. 2022;22(1):356.","journal-title":"BMC Psychiatry"},{"key":"4861_CR48","doi-asserted-by":"crossref","unstructured":"Susindar S, Sadeghi M, Huntington L, Singer A, Ferris TK. The Feeling is Real: Emotion Elicitation in Virtual Reality. Proceedings of the Human Factors and Ergonomics Society Annual Meeting. 2019;63(1):252-6.","DOI":"10.1177\/1071181319631509"},{"key":"4861_CR49","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ijhcs.2015.05.004","volume":"82","author":"A Felnhofer","year":"2015","unstructured":"Felnhofer A, Kothgassner OD, Schmidt M, Heinzle A-K, Beutl L, Hlavacs H, et al. Is virtual reality emotionally arousing? Investigating five emotion inducing virtual park scenarios. Int J Hum Comput Stud. 2015;82:48\u201356.","journal-title":"Int J Hum Comput Stud"},{"issue":"1\u20132","key":"4861_CR50","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.schres.2015.07.046","volume":"168","author":"S Potvin","year":"2015","unstructured":"Potvin S, Tikasz A, Lungu O, Dumais A, Stip E, Mendrek A. Emotion processing in treatment-resistant schizophrenia patients treated with clozapine: an fMRI study. Schizophr Res. 2015;168(1\u20132):377\u201380.","journal-title":"Schizophr Res"},{"issue":"3","key":"4861_CR51","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s12311-015-0696-2","volume":"15","author":"O Mothersill","year":"2016","unstructured":"Mothersill O, Knee-Zaska C, Donohoe G. Emotion and theory of mind in Schizophrenia-Investigating the role of the Cerebellum. Cerebellum. 2016;15(3):357\u201368.","journal-title":"Cerebellum"},{"issue":"1","key":"4861_CR52","first-page":"45","volume":"61","author":"S Gica","year":"2019","unstructured":"Gica S, Poyraz BC, Gulec H. Are emotion recognition deficits in patients with schizophrenia states or traits? A 6-month follow-up study. Indian J Psychiatry. 2019;61(1):45\u201352.","journal-title":"Indian J Psychiatry"},{"issue":"3","key":"4861_CR53","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1093\/scan\/nsaa039","volume":"15","author":"LC Kegel","year":"2020","unstructured":"Kegel LC, Brugger P, Fruhholz S, Grunwald T, Hilfiker P, Kohnen O, et al. Dynamic human and avatar facial expressions elicit differential brain responses. Soc Cogn Affect Neurosci. 2020;15(3):303\u201317.","journal-title":"Soc Cogn Affect Neurosci"},{"key":"4861_CR54","doi-asserted-by":"publisher","first-page":"827321","DOI":"10.3389\/fpsyt.2022.827321","volume":"13","author":"T Prusinski","year":"2022","unstructured":"Prusinski T. The strength of Alliance in Individual Psychotherapy and Patient\u2019s Wellbeing: the Relationships of the Therapeutic Alliance to psychological wellbeing, satisfaction with life, and flourishing in adult patients attending individual psychotherapy. Front Psychiatry. 2022;13:827321.","journal-title":"Front Psychiatry"},{"key":"4861_CR55","doi-asserted-by":"publisher","first-page":"270","DOI":"10.3389\/fpsyg.2011.00270","volume":"2","author":"RB Ardito","year":"2011","unstructured":"Ardito RB, Rabellino D. Therapeutic alliance and outcome of psychotherapy: historical excursus, measurements, and prospects for research. Front Psychol. 2011;2:270.","journal-title":"Front Psychol"},{"issue":"2","key":"4861_CR56","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1177\/0034355219847284","volume":"63","author":"T Souto","year":"2019","unstructured":"Souto T, Silva H, Leite A, Baptista A, Queir\u00f3s C, Marques A. Facial emotion recognition: virtual reality program for facial emotion Recognition\u2014A Trial Program targeted at individuals with Schizophrenia. Rehabilitation Couns Bull. 2019;63(2):79\u201390.","journal-title":"Rehabilitation Couns Bull"},{"issue":"2","key":"4861_CR57","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1159\/000101472","volume":"17","author":"S Kraemer","year":"2007","unstructured":"Kraemer S, Lihl M, Mergenthaler E. Schl\u00fcsselstunden im Verlauf kognitiver Verhaltenstherapie von schizophrenen Patienten: Ein Beitrag zur Prozessforschung. Verhaltenstherapie. 2007;17(2):90\u20139.","journal-title":"Verhaltenstherapie"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-023-04861-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-023-04861-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-023-04861-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T10:03:35Z","timestamp":1686564215000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-023-04861-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,12]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4861"],"URL":"https:\/\/doi.org\/10.1186\/s12888-023-04861-2","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,12]]},"assertion":[{"value":"29 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the institutional ethical committee. Patients that are part of this study were selected based on the proof-of-concept trial from Percy du Sert 2018 \u2018s study and Dellazizzo 2021s study [, ]. The trial was conducted in accordance with the Declaration of Helsinki and was approved by the institutional ethical committee (CER IPPM 16-17-06). The study has been approved by the ethics committee of CR-IUSMM. We obtained written informed consent from all patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"420"}}